BIOMINRISKNCT06244433
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 9 words Show 5 more changesShow less
- Trial completed
- Final enrollment: 98 participants (planned 650)
- Study completion date changed from estimate of Oct 27, 2027 to Oct 26, 2026
- Site details revised at 18 of 18 sites
- Publications: details revised at 1 of 1 entry
- Minor Trial sites expanded: 15 → 18 locationsv5
- Minor Primary completion date: Aug 2026 to Aug 27, 2026
- Study completion date: Oct 2027 to Oct 27, 2027
- Minor Study sites: 1 to 15
- Secondary endpoints expanded, about 16 words
- Collaborators: 1 to 2
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Start date changed from estimate of Feb 2024 to Aug 27, 2024
- Primary completion date: Feb 2026 to Aug 2026
- Study completion date: Apr 2027 to Oct 2027
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Identification of genetic variants
Timeframe: up to 38 months
Secondary (2)
Identification of heterozygous variants or CNVs (copy number variants)
Identification of new genotype - phenotype correlations
Arms and interventions
SUDI cases
Sudden unexpected death in infant (SUDI) cases registered within the French National Registry of SUDI
Parents
Both parents of identified SUDI
Genetic: whole genome sequencing
Sites
18 sites in 1 country